12 completed, 3 unknown, 1 active not recruiting, 1 terminated. 17 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 17 | Completed 12, Unknown 3, Active not recruiting 1, Terminated 1 |
| Phase 2 | 2 | Completed 1, Unknown 1 |
Follow Somatosensory Disorders: new trials by email Literature Review of Somatosensory Disorders trials Research Report on Somatosensory Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| STTEPP: Safety, Tolerability and Dose Limiting Toxicity of Lacosamide in Patients With Painful Chronic Pancreatitis Lacosamide - Chronic Pain, Chronic Pain Syndrome | Phase 1 | Active not recruiting | Indiana University | 21 | 2023-03-17 | 2026-06-03 |
| Dextromethorphan Effect on Central Sensitization to Pain in Healthy Volunteers Pulmodexane® 30mg, lactose - Experimental Pain, Hyperalgesia | Phase 1 | Completed | University Hospital, Clermont-Ferrand | 20 | 2015-11-01 | 2026-08-06 |
| Fenobam on Heat/Capsaicin Induced Hyperalgesia in Healthy Volunteers Fenobam, Placebo - Hyperalgesia, Allodynia | Phase 1 | Completed | Laura Cavallone | 33 | 2014-01-01 | 2016-04-29 |
| Effect of High Dose Naloxone on Secondary Hyperalgesia Naloxone (2 mg/kg), Placebo - Hyperalgesia, Pain | Phase 1 | Completed | Copenhagen University Hospital, Rigshospitalet | 15 | 2013-06-01 | 2014-02-25 |
| Evaluation of the Antihyperalgesic Effect of Tapentadol in Two Human Experimental Models Tapentadol immediate release, placebo - Pain, Hyperalgesia | Phase 1 | Terminated | University Hospital Schleswig-Holstein | 24 | 2012-10-01 | 2022-09-14 |
| Hyperalgesia and Pain Nitrous Oxide - Hyperalgesia | Phase 1 | Completed | Air Liquide Santé International | 20 | 2012-01-01 | 2025-09-11 |
| Gabapentin and Donepezil Combination on Experimental Human Pain Models Gabapentin lower dose, Donepezil, Placebo (Dop) - Pain, Neuropathic | Phase 1 | Completed | GlaxoSmithKline | 48 | 2011-10-11 | 2017-06-12 |
| Determine the Effect of AZD3161,Injected Intradermally, on Quantitative Sensory Testing Variables in Normal and Ultraviolet-C (UVC) Exposed Skin in Healthy Volunteers AZD3161, Lidocaine, AZD3161 Placebo - Peripheral Neuropathic Pain, Nociceptive Pain | Phase 1 | Completed | AstraZeneca | 26 | 2010-12-01 | 2011-04-12 |
| Effects of Milnacipran on Widespread Mechanical and Thermal Hyperalgesia of Fibromyalgia Patients Milnacipran - Fibromyalgia | Phase 1 | Completed | University of Florida | 51 | 2009-11-01 | 2014-07-31 |
| A Safety Tolerance and Experimental Hyperalgesia Study of Oral NGX426 in Healthy Male Voluneteers Placebo, Oral NGX426 (Powder in solution) - Healthy, Hyperalgesia | Phase 1 | Completed | TorreyPines Therapeutics | 18 | 2008-05-01 | 2009-01-30 |
| A Study Of GSK189254 And Duloxetine In The Electrical Hyperalgesia Model Of Healthy Volunteers Duloxetine, GSK189254, GSK189254 Placebo - Hyperalgesia | Phase 1 | Completed | GlaxoSmithKline | 40 | 2006-10-02 | 2017-08-07 |
| Effects of Lidocaine Patch on Intradermal Capsaicin Induced Pain and Hyperalgesia Lidoderm Patch - Pain, Hyperalgesia | Phase 1 | Completed | University of California, San Diego | 12 | 2005-12-01 | 2006-09-08 |
| Use of a Vibrotactile Sensory Prosthesis in Patients With Postural Imbalance and Spatial Disorientation Vibrotactile feedback - Vestibular Diseases, Peripheral Neuropathies | Phase 1 | Unknown | Imperial College London | 30 | 2005-01-01 | 2016-11-11 |
| Effects of N-Methyl-D-Aspartate (NMDA)-Receptor Antagonism on Hyperalgesia, Opioid Use, and Pain After Radical Prostatectomy Amantadine - Hyperalgesia, Pain | Phase 1 / Phase 2 | Unknown | University Health Network, Toronto | 132 | 2004-01-01 | 2006-03-14 |
| GW406381 In Patients With Peripheral Nerve Injury GW406381 - Hyperalgesia, Neurodynia | Phase 1 | Completed | GlaxoSmithKline | 40 | 2003-09-01 | 2009-02-23 |
| Hyperalgesia in Methadone Patients: Can it be Treated? dextromethorphan - Opioid-induced Hyperalgesia | Phase 1 | Unknown | National Institute on Drug Abuse (NIDA) | 40 | 2002-09-01 | 2017-01-11 |
| Analgesic Efficacy of Smoked Cannabis Smoked Cannabis - Pain, Hyperalgesia | Phase 1 / Phase 2 | Completed | Center for Medicinal Cannabis Research | 15 | 2002-02-01 | 2006-06-23 |
Hyperalgesia (16) · Pain (10) · Neuralgia (2) · Chronic Pain (1) · Digestive System Diseases (1) · Fibromyalgia (1) · Marijuana Abuse (1) · Nociceptive Pain (1) · Opioid-Related Disorders (1) · Pancreatic Diseases (1) · Pancreatitis (1) · Pancreatitis, Chronic (1) · Paresthesia (1) · Perceptual Disorders (1) · Peripheral Nerve Injuries (1)
Nervous System Diseases (17) · Neurologic Manifestations (17) · Pathological Conditions, Signs and Symptoms (17) · Sensation Disorders (17) · Signs and Symptoms (17) · Neuromuscular Diseases (4) · Chemically-Induced Disorders (2) · Mental Disorders (2) · Pain (2) · Peripheral Nervous System Diseases (2) · Substance-Related Disorders (2) · Chronic Disease (1) · Disease Attributes (1) · Ear Diseases (1)
Lidocaine (2) · 6-((3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy)-N-methyl-3-pyridinecarboxamide (1) · Amantadine (1) · Dextromethorphan (1) · Donepezil (1) · Duloxetine Hydrochloride (1) · GW406381X (1) · Gabapentin (1) · Lacosamide (1) · Lactose (1) · Milnacipran (1) · Naloxone (1) · Nitrous Oxide (1) · Powders (1) · Solutions (1)
GlaxoSmithKline (3) · Air Liquide Santé International (1) · AstraZeneca (1) · Center for Medicinal Cannabis Research (1) · Copenhagen University Hospital, Rigshospitalet (1) · Imperial College London (1) · Indiana University (1) · Laura Cavallone (1) · National Institute on Drug Abuse (NIDA) (1) · TorreyPines Therapeutics (1) · University Health Network, Toronto (1) · University Hospital Schleswig-Holstein (1) · University Hospital, Clermont-Ferrand (1) · University of California, San Diego (1) · University of Florida (1)
United States (7) · United Kingdom (5) · Germany (2) · Canada (1) · Denmark (1) · France (1)
Mark Wallace, M.D. (2) · Adolfo M Bronstein, Pr, MD (1) · Aynur Unalp-Arida, MD, PhD (1) · Bo Fransson (1) · Christopher Kennard, Pr, MD (1) · Darren Wilbraham, MD, MBBS DCPSA (1) · Joergen B Dahl, M.D., DMSc (1) · Laura F Cavallone, M.D. (1) · Lucia Gagliese, PhD (1) · Mads U. Werner, M.D., Ph.D., DMSc (1) · Margaret A Compton, RN, PhD (1)
PMID 10870744, PMID 11165371, PMID 11786502, PMID 14621285, PMID 15647484, PMID 15800228, PMID 16508405, PMID 17123731, PMID 17237664, PMID 17433624, PMID 17635557, PMID 17853395, PMID 18294378, PMID 18362258, PMID 18378801, PMID 18419722, PMID 18619874, PMID 18774343, PMID 19409861, PMID 19789074, PMID 20031953, PMID 20086062, PMID 21029787, PMID 21148579, PMID 21249671, PMID 21412914, PMID 21765969, PMID 22336864, PMID 22494121, PMID 22898544, PMID 24661411, PMID 24867013, PMID 25218827, PMID 25221944, PMID 25418676, PMID 25872113, PMID 25957198, PMID 25998206, PMID 26029937, PMID 26987082, PMID 27295489, PMID 27407096, PMID 28074005, PMID 28106092, PMID 28119481, PMID 28409480, PMID 28767350, PMID 29671994, PMID 29769209, PMID 30325859
2015 (1), R01DK132709 (1)